
    
      Due to a large proportion of patients that could benefit from Dantonic treatment is likely to
      take warfarin concomitantly. And there is no systematic experience of warfarin drug-drug
      interaction between Dantonic and warfarin on humans. It is highly relevant to investigate the
      potential interaction of theses two drugs.

      Primary endpoint:

      â€¢The change in INR with T89 (Day 25) compared with that without T89 (Day 18)

      Secondary endpoints:

        -  The change in PK variables for R-warfarin and S-warfarin on Day 17 compared with those
           on Day 24

        -  Safety assessments across all time points
    
  